SCHEMBL5347650

SCHEMBL5347650

O=C(C=Cc1ccccc1)/C=C\c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 1.00
CYP2C9 P11712 3/20 1.00
F3 P13726 3/20 1.00
CYP1A2 P05177 3/20 1.00
PLIN1 O60240 2/20 1.00
LMNA P02545 2/20 1.00
RECQL P46063 2/20 1.00
PLIN5 Q00G26 2/20 1.00
ABHD5 Q8WTS1 2/20 1.00
CYP2D6 P10635 2/20 1.00
ALDH1A1 P00352 2/20 1.00
SMN1; SMN2 Q16637 1/20 1.00
HDAC3 O15379 2/20 0.73
HDAC4 P56524 2/20 0.73
HDAC1 Q13547 2/20 0.73
HDAC2 Q92769 2/20 0.73
HDAC8 Q9BY41 2/20 0.73
HDAC6 Q9UBN7 2/20 0.73
TNKS O95271 1/20 0.73
HCAR2 Q8TDS4 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20856054 1.00 MAPT (1.00) MAPTCYP2C9F3CYP1A2PLIN1
SCHEMBL28435740 1.00 MAPT (1.00) MAPTCYP2C9F3CYP1A2PLIN1
SCHEMBL20518814 1.00 MAPT (1.00) MAPTCYP2C9F3CYP1A2PLIN1
SCHEMBL478244 1.00 MAPT (1.00) MAPTCYP2C9F3CYP1A2PLIN1
SCHEMBL22146 1.00 MAPT (1.00) MAPTCYP2C9F3CYP1A2PLIN1
SCHEMBL20846 1.00 MAPT (1.00) MAPTCYP2C9F3CYP1A2PLIN1
SCHEMBL28181 1.00 MAPT (1.00) MAPTCYP2C9F3CYP1A2PLIN1
SCHEMBL187662 0.97 MAPT (0.95) MAPTCYP2C9F3CYP1A2PLIN1
SCHEMBL21879664 0.97 MAPT (0.95) MAPTCYP2C9F3CYP1A2PLIN1
SCHEMBL7265797 0.97 MAPT (0.95) MAPTCYP2C9F3CYP1A2PLIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115925613-A Preparation method of near-infrared two-region squaraine type fluorescence imaging reagent, nano-composite and application thereof 南昌大学 2023-04-07 CN claimed
CN-115093313-A Cyclopentadiene derived from multi-methyl substituted spiroindane, rhodium complex thereof, preparation method, intermediate and application 中国科学院上海有机化学研究所 2022-09-23 CN claimed
WO-2007089193-A1 A PROCESS FOR PREPARING 2-HYDROXY-3- [5- (MORPHOLIN-4-YLMETHYL)PYRIDIN-2-YL] LH-INDOLE-5-CARBONITRILE AS A FREE BASE OR SALTS THEREOF ASTRAZENECA AB (SE) 2007-08-09 WO claimed
CN-114349773-B Carborane orange luminescent material, preparation method thereof and luminescent film 盐城工学院 2023-08-18 CN disclosed
CN-109804043-B Organic light emitting element having long life, low voltage and high efficiency characteristics SFC株式会社 2023-05-30 CN disclosed
CN-115925613-A Preparation method of near-infrared two-region squaraine type fluorescence imaging reagent, nano-composite and application thereof 南昌大学 2023-04-07 CN disclosed
CN-115093313-A Cyclopentadiene derived from multi-methyl substituted spiroindane, rhodium complex thereof, preparation method, intermediate and application 中国科学院上海有机化学研究所 2022-09-23 CN disclosed
CN-114478499-A Spirofluorene anthracene compound and application thereof 阜阳欣奕华材料科技有限公司 2022-05-13 CN disclosed
CN-109804009-B Organic light emitting diode 株式会社LG化学 2020-10-16 CN disclosed
CN-110832657-A Organic light emitting element with high efficiency SFC株式会社 2020-02-21 CN disclosed
WO-2019063748-A1 ROR-GAMMA INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2019-04-04 WO disclosed
EP-1105389-A4 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2001-10-17 EP disclosed
EP-1105389-A1 INTEGRIN RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2001-06-13 EP disclosed
WO-2001023346-A2 PROCESS FOR PHENYLACETIC ACID DERIVATIVES NOVARTIS AG (CH) 2001-04-05 WO disclosed
EP-1040111-A1 INTEGRIN RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2000-10-04 EP disclosed
US-6090944-A Alkanoic acid derivatives as αv integrin receptor antagonists MERCK & CO., INC. (US) 2000-07-18 US disclosed
WO-2000009503-A1 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2000-02-24 WO disclosed
US-6017926-A Integrin receptor antagonists MERCK & CO., INC. (US) 2000-01-25 US disclosed
WO-1999031099-A1 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1999-06-24 WO disclosed
US-4347232-A Preparation of hydrogen peroxide from its elements FMC CORPORATION (US) 1982-08-31 US disclosed